Rational development of novel treatment regimens to improve the efficacy of estrogen therapy in anti-estrogen-resistant ER plus breast cancer

被引：0
|
作者：
Traphagen, Nicole A. [1 ]
Jiang, Amanda [2 ]
Hosford, Sarah R. [1 ]
Miller, Todd W. [1 ]
机构：
[1] Dartmouth Geisel Sch Med, Lebanon, NH USA
[2] Dartmouth Coll, Hanover, NH 03755 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4359
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4359
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Estrogen receptor alpha reactivation for the treatment of anti-estrogen-resistant breast cancer
    Hosford, S. R.
    Kaufman, P. A.
    Miller, T. W.
    CANCER RESEARCH, 2016, 76
  • [2] Anti-estrogen-resistant breast cancer cells are sensitive to cisplatin plus TRAIL treatment
    Yin, Shuping
    Rishi, Arun K.
    Reddy, Kaladhar B.
    ONCOLOGY REPORTS, 2015, 33 (03) : 1475 - 1480
  • [3] Enhancing response to estrogen therapy in ER plus breast cancer with novel scheduling and dosing regimens
    Traphagen, N. A.
    Hosford, S. R.
    Miller, T. W.
    CANCER RESEARCH, 2019, 79 (04)
  • [4] ER reactivation rapidly elicits cell death effects in anti-estrogen-resistant breast cancer
    Hosford, S. R.
    Kettenbach, A. N.
    Varn, F. S.
    Cheng, C.
    Miller, T. W.
    CANCER RESEARCH, 2017, 77
  • [5] Altered signaling in anti-estrogen-resistant human breast cancer cells
    Lykkesfeldt, AE
    Frogne, T
    Jepsen, JS
    Fog, CK
    Larsen, SS
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S35 - S36
  • [6] Altered signaling in anti-estrogen-resistant human breast cancer cells
    AE Lykkesfeldt
    T Frogne
    JS Jepsen
    CK Fog
    SS Larsen
    Breast Cancer Research, 7
  • [7] Novel dual modulator of estrogen sulfatase and estrogen receptor (ER) for the treatment of ER plus breast cancer.
    Chao, WR
    Peters, RH
    Zaveri, N
    Tanabe, M
    Yamada, Y
    Toko, T
    Asao, T
    Eshima, K
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S103 - S103
  • [8] Development of novel breast cancer therapeutics for anti-estrogen resistant breast cancer
    Ma, Yongxian
    Preet, Anju
    Hu, Changyan
    Kumar, Akshay
    Ma, James
    Tomita, York
    Rosen, Eliot M.
    CANCER RESEARCH, 2013, 73 (08)
  • [9] Anti-estrogen-resistant proliferation of human breast cancer cells is regulated by different signaling pathways
    Dorssers, Lambert C. J.
    Van Agthoven, Ton
    Brinkman, Arend
    Meijer, Danielle
    CANCER RESEARCH, 2006, 66 (08)
  • [10] The anti-estrogen effect of metformin in ERα plus breast cancer and tamoxifen resistant cell lines
    Kim, Jinkyoung
    Lee, Jiyun
    Jang, Soonyoung
    Kim, Chungyeul
    Kim, Aeree
    CANCER RESEARCH, 2014, 74 (19)
12345